Trial · NCT03762265
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| BT Period: Weeks 1 to 37 | STARTED | Placebo Then Rilzabrutinib | 66 | |
| BT Period: Weeks 1 to 37 | STARTED | Rilzabrutinib Then Rilzabrutinib | 65 | |
| BT Period: Weeks 1 to 37 | COMPLETED | Placebo Then Rilzabrutinib | 51 | |
| BT Period: Weeks 1 to 37 | COMPLETED | Rilzabrutinib Then Rilzabrutinib | 62 | |
| BT Period: Weeks 1 to 37 | NOT COMPLETED | Placebo Then Rilzabrutinib | 15 | |
| BT Period: Weeks 1 to 37 | NOT COMPLETED | Rilzabrutinib Then Rilzabrutinib | 3 | |
| OLE Period: Weeks 37 to 61 | STARTED | Placebo Then Rilzabrutinib | 51 | |
| OLE Period: Weeks 37 to 61 | STARTED | Rilzabrutinib Then Rilzabrutinib | 61 | |
| OLE Period: Weeks 37 to 61 | COMPLETED | Placebo Then Rilzabrutinib | 35 | |
| OLE Period: Weeks 37 to 61 | COMPLETED | Rilzabrutinib Then Rilzabrutinib | 45 | |
| OLE Period: Weeks 37 to 61 | NOT COMPLETED | Placebo Then Rilzabrutinib | 16 | |
| OLE Period: Weeks 37 to 61 | NOT COMPLETED | Rilzabrutinib Then Rilzabrutinib | 16 | |
| LTE Period: Weeks 61 to 109 | STARTED | Placebo Then Rilzabrutinib | 35 | |
| LTE Period: Weeks 61 to 109 | STARTED | Rilzabrutinib Then Rilzabrutinib | 34 | |
| LTE Period: Weeks 61 to 109 | COMPLETED | Placebo Then Rilzabrutinib | 6 | |
| LTE Period: Weeks 61 to 109 | COMPLETED | Rilzabrutinib Then Rilzabrutinib | 6 | |
| LTE Period: Weeks 61 to 109 | NOT COMPLETED | Placebo Then Rilzabrutinib | 29 | |
| LTE Period: Weeks 61 to 109 | NOT COMPLETED | Rilzabrutinib Then Rilzabrutinib | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03762265/flow